Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic mechanisms of resistance to venetoclax in multiple myeloma with t(11;14)(CCND1;IGH).

Blood·2026
Same author

Safety landscape of bispecific antibody therapy in non-Hodgkin lymphoma: a meta-analysis.

Blood neoplasia·2025
Same author

Endovascular Management of Severe Peripheral Artery Disease Isolated to the Popliteal Artery Shows Comparable Outcomes Regardless of Treatment Modality.

Annals of vascular surgery·2025
Same author

Fenestrated Endovascular Aortic Aneurysm Repair Is Associated with Increased Sac Regression on Postoperative Volumetric Analysis Compared to Endovascular Aortic Aneurysm Repair.

Annals of vascular surgery·2025
Same author

Exploring BCL2 regulation and upstream signaling transduction in venetoclax resistance in multiple myeloma: potential avenues for therapeutic intervention.

Blood cancer journal·2025
Same author

Total Contact Casting Remains an Effective Modality for Treatment of Diabetic Foot Ulcers.

Vascular and endovascular surgery·2024
Same journal

Impact of Insurance Status on Urgency of Presentation and Perioperative Outcomes Following Endovascular Repair of Abdominal Aortic Aneurysms: A Vascular Quality Initiative Analysis.

Journal of vascular surgery·2026
Same journal

Large language models routinely overcode peripheral endovascular procedures relative to professional coders.

Journal of vascular surgery·2026
Same journal

Comparison of Deep and Non-Deep Hypothermia in Thoracic and Thoracoabdominal Aortic Surgery: A Systematic Review and Meta-Analysis.

Journal of vascular surgery·2026
Same journal

Horner Syndrome Secondary to Giant Shamblin Type III Carotid Body Tumor.

Journal of vascular surgery·2026
Same journal

Three-Year Outcomes of Supera Interwoven Nitinol Stents Versus Eluvia Drug-Eluting Stents in Severely Calcified Femoropopliteal Lesions.

Journal of vascular surgery·2026
Same journal

Comparative Effectiveness of Drug-coated and Uncoated Balloon Angioplasty in Dysfunctional Hemodialysis Circuits among Medicare Beneficiaries.

Journal of vascular surgery·2026
See all related articles

Related Experiment Video

Updated: Jun 11, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Intermediate-term EVAR outcomes in octogenarians.

Rodrigo Fonseca1, Caron Rockman, Abhishek Pitti

  • 1NYU Medical Center, New York, NY 10016, USA.

Journal of Vascular Surgery
|July 13, 2010
PubMed
Summary
This summary is machine-generated.

Endovascular abdominal aortic aneurysm repair (EVAR) is safe for octogenarians, with similar major complication rates to younger patients. However, octogenarians face higher risks of pulmonary and access-site complications.

Related Experiment Videos

Last Updated: Jun 11, 2026

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
12:59

Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People

Published on: July 5, 2017

Area of Science:

  • Vascular Surgery
  • Endovascular Interventions
  • Geriatric Medicine

Background:

  • Endovascular abdominal aortic aneurysm repair (EVAR) offers reduced perioperative risks compared to open repair.
  • Octogenarians are increasingly offered EVAR due to its less invasive nature.
  • Outcomes of EVAR in octogenarians versus younger patients require detailed investigation.

Purpose of the Study:

  • To compare periprocedural and late outcomes of EVAR in octogenarians versus patients under 80 years old.
  • To evaluate the safety and efficacy of EVAR in the elderly population.

Main Methods:

  • Retrospective analysis of 322 EVAR patients from January 2003 to May 2008.
  • Comparison between 117 octogenarians and 205 younger patients (<80 years).
  • Analysis of demographic data, aneurysm details, perioperative morbidity, mortality, and late outcomes.

Main Results:

  • Octogenarians had higher rates of comorbidities: diabetes (51% vs 23%), CAD (45% vs 32%), COPD (44% vs 30%), and renal insufficiency (57% vs 31%).
  • No significant differences in perioperative myocardial infarction, stroke, death, or ischemic complications.
  • Octogenarians experienced higher rates of pulmonary complications (5.1% vs 1%) and access-site hematomas (12% vs 2.4%). Combined perioperative morbidity was higher (27.4% vs 11.7%).
  • Younger patients had a higher incidence of type II endoleaks at 5-year follow-up.

Conclusions:

  • EVAR is safe and effective in octogenarians, with comparable rates of major complications (MI, stroke, death) to younger individuals.
  • Octogenarians exhibit increased risks of access-site hematomas and pulmonary complications post-EVAR.
  • EVAR is a suitable treatment for elderly patients with appropriate preoperative assessment and monitoring.